Search results
America's poverty line is letting millions slip through the cracks — here's how we could fix it
INSIDER via Yahoo News· 7 days ago"But I'm too homeless to get a job because I don't know where I'm going to live in three weeks. What...
Confronting the Backlash Against QALYs: Key Insi | Newswise
Newswise· 6 days agoThe Debate Continues,” by Nancy J Devlin, PhD, Michael F. Drummond, MCom, DPhil, and C. Daniel Mullins, PhD, provides...
Zacks Industry Outlook Highlights Boston Scientific, ResMed, Lantheus and Haemonetics
Zacks via Yahoo Finance· 3 days agoOutside the United States, it sells its products via a combination of direct distribution in Canada...
I’m an Economist: 10 Ways Trump vs. Biden Won’t Impact Your Money
GOBankingRates via Yahoo Finance· 6 days agoThis fall, the presidential election will be front and center in most Americans' minds. The final...
‘I prayed for a bed’: the fight for my father in the US healthcare system
The Guardian via Yahoo News· 6 days agoMy dad’s stroke marked the beginning of the rest of our lives. Navigating his health, a web of...
Sale of Roger Williams, Fatima hospitals can proceed if conditions are met
Rhode Island Current via Yahoo News· 4 days agoAn Atlanta-based nonprofit can take over Our Lady of Fatima Hospital in North Providence and Roger...
Analysis | Like doctors, more nurse practitioners are heading into specialty care
Washington Post· 7 days agoToday I’m writing about how nurse practitioners are turning up in specialties like dermatology and...
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 5 days agoReal-world study data suggest there is little difference among five drug classes commonly used to...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen...
Morningstar· 2 days agoPomerantz LLP announces that a class action lawsuit has been filed against Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB) and certain officers. The class action, filed in the
Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial
Medscape· 5 days agoThe primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce...